Clinical Trial Update: Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon [Phase 3]

View source ↗

Summary

Phase III trial of a topical gel for Raynaud's Disease has completed enrollment with status updated to completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Raynaud Disease

Drugs mentioned

• Topical Gel for Raynaud's Phenomenon

Snippet

Sponsor: MediQuest Therapeutics | Conditions: Raynaud's Disease | Phase 3 | Status: COMPLETED